Advertisement
Journal Home
Search for

Volume 79, Issue 2, Pages 117-121 (February 2009)


View previous. 9 of 18 View next.

Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass

Roberto Uras, Marisa Orrù, Rossella Etzi, Giangavino Peppi, Maria Francesca Marotto, Monica Pilloni, Pierina Zedda, Stefano Lello, Gian Benedetto MelisCorresponding Author Informationemail address, Anna Maria Paoletti

Received 18 April 2008; received in revised form 26 August 2008; accepted 26 August 2008. published online 10 October 2008.

Abstract 

Background

We aimed to evaluate whether a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol (EE2) plus 2 mg of chlormadinone acetate (CMA) (EE2+CMA) alters body weight (BW) and body composition of healthy young women with normal menstrual cycles. The results in treated subjects were compared to those obtained in nontreated women as control.

Study Design

Multifrequency bioelectrical impedance analysis (MF-BIA) was performed in 48 healthy young women during the follicular phase of their menstrual cycle. Of this group, 24 women were treated with EE2+CMA, and the MF-BIA was repeated at the third and sixth cycle of treatment. The remaining 24 women were submitted to the same examinations after three and six cycles without any treatment. Total body water (TBW), intracellular water (ICW), extracellular water (ECW), fat mass (FM) and fat-free mass (FFM) were calculated. Waist-to-hip ratio (WHR), BW, blood pressure, and the plasma concentrations of electrolytes were also measured at each visit.

Results

Mean FM significantly (p<.05) decreased in the EE2+CMA group from basal levels of 14.23±1.03 to 13.51±1.09 and 12.71±1.02 kg at the third and sixth cycle of treatment, respectively. Stable values were seen in the control group. During observation, other parameters (BW, WHR, TBW, ECW, ICW, FFM) remained unchanged in all subjects.

Conclusions

EE2+CMA reduces FM without altering TBW, ICW, ECW. These preliminary results suggest that progestational activity of CMA could balance both fluid retention and weight gain elicited by EE2.

Department of Obstetrics and Gynaecology, University of Cagliari, 09124 Cagliari, Italy

Corresponding Author InformationCorresponding author. Clinica Ginecologica Ostetrica e di Fisiopatologia della Riproduzione Umana del Dipartimento Chirurgico Materno-Infantile e di Scienze delle Immagini, Università degli Studi di Cagliari, Via Ospedale 46, 09124 Cagliari, Italy. Tel.: +39 070 652797; fax: +39 070 668575.

PII: S0010-7824(08)00429-0

doi:10.1016/j.contraception.2008.08.007


View previous. 9 of 18 View next.

Advertisement